Research progress of targeted therapy for bronchial asthma

金美玲,叶伶,朱桂萍
DOI: https://doi.org/10.3760/cma.j.cn131368-20200619-00524
2021-01-01
Abstract:Bronchial asthma (asthma) is a common chronic airway inflammatory disease with heterogeneity.Although various treatments are available, including inhaled corticosteroids, many asthmatics are still not well controlled.According to studies, many inflammatory mediators are involved in the pathogenesis of asthma which result in a variety of monoclonal antibodies and small-molecule chemotherapeutic drugs targeting the inflammatory mediators being developed for the treatment of asthma.Thus, treatment of asthma enters the era of targeted therapy.This review discusses the progress of targeted therapy in asthma and possible new targets so as to provide more individualized therapy for patients.
What problem does this paper attempt to address?